1. Industries
  2. Pharmaceuticals companies

Pharmaceuticals Companies & Verified Decision-Maker Emails

Pharmaceutical companies research, develop, manufacture, and distribute prescription medications and therapeutic treatments. Decision-makers typically include R&D Directors, Regulatory Affairs Leaders, and Commercial Executives.

Engage pharmaceutical organizations advancing clinical trials, expanding production capacity, and scaling distribution networks.

Identify and research relevant companies and decision-makers in the Pharmaceuticals sector. Access verified business emails and direct contact details to support targeted lead generation, outreach campaigns, and higher conversion rates. Filter prospects by location, category, company size, and operating status to build precise, high-quality lists.

🔥 Why Use Our Directory?

Built for Real B2B Growth

Trusted by SDRs, agencies & founders who need verified, export-ready data.

📧

95%+ Email Verification Rate

Highly accurate contact data to minimize bounce rates and safeguard sender reputation.

🔄

Weekly Database Updates

Fresh company and contact records updated continuously.

🎯

Advanced Filtering

Filter by industry, country, company size & funding stage.

📊

Export-Ready CSV

Download clean, structured CSV files ready for your CRM or outreach tool.

Explore Plans

Companies

Found 258 firms

Prospects

Found 808 prospects · 126 Decision-Makers

Search Results

Showing 1–20 of 258 verified Pharmaceuticals companies — browse profiles, find decision-makers, and export contacts.

Gilead Sciences

gilead.com

HQ: Foster City, California, United States

HQ: Foster City, California, United States

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active

  • Ahmed Afifi

    Vice President - Region Head Latin America

    a*********i@gilead.com

  • Kelsey Reedy

    Talent Advisor

    k**********y@gilead.com

  • Unclassified inbox

    public_affairs@gilead.com

  • Unclassified inbox

    bernard.murray@gilead.com

Show more 28 emails
View Gilead Sciences Profile Verify Gilead Sciences Emails Export Gilead Sciences Prospects

Seagen

seagen.com

HQ: Bothell, Washington, United States

HQ: Bothell, Washington, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active

  • Guy Padbury

    Senior Vice President, Translational Sciences

    g******y@seagen.com

  • Bryce Mansfield

    Executive Director, R&D Quality

    b********d@seagen.com

  • General Inquiries

    contact@seagen.com

  • Unclassified inbox

    pcarter@seagen.com

Show more 16 emails
View Seagen Profile Verify Seagen Emails Export Seagen Prospects

AbbVie

abbvie.com

HQ: North Chicago, Illinois, United States

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active

  • Melanie Cohen

    m***********n@abbvie.com

  • Nancy Vangeys

    n***********s@abbvie.com

  • Customer Service

    customerservice@abbvie.com

  • Unclassified inbox

    talentacquisition@abbvie.com

Show more 311 emails
View AbbVie Profile Verify AbbVie Emails Export AbbVie Prospects

AstraZeneca

astrazeneca.com

HQ: Cambridge, Cambridgeshire, United Kingdom

HQ: Cambridge, Cambridgeshire, United Kingdom

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active

  • Marc Dunoyer

    Chief Strategy Officer

    m**********r@astrazeneca.com

  • Richard Gallo

    Oncology Contract Strategy Manager

    r***********o@astrazeneca.com

  • General Inquiries

    contact@astrazeneca.com

  • General Inquiries

    help@astrazeneca.com

Show more 24 emails
View AstraZeneca Profile Verify AstraZeneca Emails Export AstraZeneca Prospects

Roche

roche.com

HQ: Basel, Basel-Stadt, Switzerland

HQ: Basel, Basel-Stadt, Switzerland

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active

  • Jason Hall

    Senior Business Analyst

    j********l@roche.com

  • Thomas Schinecker

    t***************r@roche.com

  • Unclassified inbox

    patientcare@roche.com

  • Unclassified inbox

    new_zealand.dia_communications@roche.com

Show more 24 emails
View Roche Profile Verify Roche Emails Export Roche Prospects

Bristol-Myers Squibb

bms.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital

  • John damonti

    Foundation President

    d******j@bms.com

  • Ron Behling

    r************g@bms.com

  • Unclassified inbox

    drugsafety@celgene.com

  • Unclassified inbox

    carmen.m.lopez@bms.com

Show more 22 emails
View Bristol-Myers Squibb Profile Verify Bristol-Myers Squibb Emails Export Bristol-Myers Squibb Prospects

Johnson Matthey

matthey.com

HQ: London, England, United Kingdom

HQ: London, England, United Kingdom

Specialized In: Manufacturing & Industrial, Technology & Software, Pharmaceuticals, Staffing Agencies

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 20, 2024
Founded Date: 1817
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:JMPLF
Operating Status: Active

  • Margaret Ruiseal

    Global HR Transformation Director

    m**************l@matthey.com

  • Erwin Teirlinck

    Business Development Manager

    e*************k@matthey.com

  • Unclassified inbox

    elmar.braeuning@matthey.com

  • Unclassified inbox

    mj@matthey.com

Show more 21 emails
View Johnson Matthey Profile Verify Johnson Matthey Emails Export Johnson Matthey Prospects

Moderna

modernatx.com

HQ: Cambridge, MA

HQ: Cambridge, MA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank

  • Huijuan Li

    Head, Analytical Development

    h********i@modernatx.com

  • Kerry Salandria

    Associate Director, Analytical Operations

    k*************a@modernatx.com

  • Unclassified inbox

    WeCare@modernatx.com

  • Unclassified inbox

    Grace.Chen@modernatx.com

Show more 17 emails
View Moderna Profile Verify Moderna Emails Export Moderna Prospects

Amgen

amgen.com

HQ: Thousand Oaks, California, United States

HQ: Thousand Oaks, California, United States

Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active

  • Esteban Santos

    Executive Vice President, Operations

    e******s@amgen.com

  • Bob Bradway

    Chief Executive Officer

    b******y@amgen.com

  • Unclassified inbox

    HCCIME@amgen.com

  • Unclassified inbox

    medinfocanada@amgen.com

Show more 17 emails
View Amgen Profile Verify Amgen Emails Export Amgen Prospects

Vertex Pharmaceuticals

vrtx.com

HQ: Boston, MA

HQ: Boston, MA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active

  • Thomas Carney

    Manager (GMP facility focus), Project Management Office, Global Capital Project Management

    t***********y@vrtx.com

  • Gillian

    Vice President, Strategic Operations, Regulatory Affairs and Quality

    g@vrtx.com

  • General Inquiries

    mediainfo@vrtx.com

  • Unclassified inbox

    cherif_benattia@vrtx.com

Show more 14 emails
View Vertex Pharmaceuticals Profile Verify Vertex Pharmaceuticals Emails Export Vertex Pharmaceuticals Prospects

Jazz Pharmaceuticals

jazzpharma.com

HQ: Palo Alto, CA

HQ: Palo Alto, CA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active

  • Bruce Cozadd

    Chief Executive Officer

    b**********d@jazzpharma.com

  • Charlotte Nortvedt

    c****************t@jazzpharma.com

  • General Inquiries

    investorinfo@jazzpharma.com

  • General Inquiries

    contact@jazzpharma.com

Show more 11 emails
View Jazz Pharmaceuticals Profile Verify Jazz Pharmaceuticals Emails Export Jazz Pharmaceuticals Prospects

Horizon Pharma

horizontherapeutics.com

HQ: Northbrook, Illinois, United States

HQ: Northbrook, Illinois, United States

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics

Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active

  • Shvetali Thatte

    s*************e@horizontherapeutics.com.If

    2**********0

  • Tina Ventura

    t**********a@horizontherapeutics.com

  • Customer Service

    customerservice@horizontherapeutics.com

  • Unclassified inbox

    jwhalen@horizonpharma.com

Show more 10 emails
View Horizon Pharma Profile Verify Horizon Pharma Emails Export Horizon Pharma Prospects

Albany Molecular Research

amriglobal.com

HQ: Albany, New York, United States

HQ: Albany, New York, United States

Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals

Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active

  • Andrew Boze

    Research Scientist I

    a*********e@amriglobal.com

  • Steven Pawlows

    Senior Manager

    s************s@amriglobal.com

  • General Inquiries

    InvestorInfo@amriglobal.com

  • Unclassified inbox

    patty.eisenhaur@amriglobal.com

Show more 9 emails
View Albany Molecular Research Profile Verify Albany Molecular Research Emails Export Albany Molecular Research Prospects

KBI Biopharma

kbibiopharma.com

HQ: Durham, NC

HQ: Durham, NC

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial

Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active

  • Chad Cleveland

    Director - Data Integrity | Global Quality & Compliance

    c********d@kbibiopharma.com

  • Nicolas Fouque

    Director of Manufacturing Science and Technologies - Geneva

    n*****e@kbibiopharma.com

  • Unclassified inbox

    swakefield@kbibiopharma.com

  • General Inquiries

    contact@kbibiopharma.com

Show more 9 emails
View KBI Biopharma Profile Verify KBI Biopharma Emails Export KBI Biopharma Prospects

Rakuten Medical

rakuten-med.com

HQ: San Diego, CA

HQ: San Diego, CA

Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics

Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active

  • Natalie Huang

    People Operations Generalist (HR)

    n****g@rakuten-med.com

  • Shashank Basavaraju

    Associate Manager, Technical Operations & Global Supply Chain

    s*********u@rakuten-med.com

  • Unclassified inbox

    info.tw@rakuten-med.com

  • Unclassified inbox

    j.d@rakuten-med.com

Show more 8 emails
View Rakuten Medical Profile Verify Rakuten Medical Emails Export Rakuten Medical Prospects

Sartorius

sartorius.com

HQ: Göttingen, Niedersachsen, Germany

HQ: Göttingen, Niedersachsen, Germany

Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals

Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active

  • Joachim Kreuzburg

    Chairman of the Executive Board and CEO

    j***************g@sartorius.com

  • Mareva Gueneron

    Head Of Project Management Office (PMO)

    m*************n@sartorius.com

  • General Inquiries

    info@sartorius.com

  • Admin Team

    admin@sartorius.com

Show more 8 emails
View Sartorius Profile Verify Sartorius Emails Export Sartorius Prospects

Sorrento Therapeutics

sorrentotherapeutics.com

HQ: San Diego, CA

HQ: San Diego, CA

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical

Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active

  • Jaisim Shah

    President & Chief Executive Officer

    j***h@sorrentotherapeutics.com

  • Yan Li

    Senior Scientist, Antibody Technology Development

    y*i@sorrentotherapeutics.com

  • General Inquiries

    info@sorrentotherapeutics.com

  • Admin Team

    admin@sorrentotherapeutics.com

Show more 8 emails
View Sorrento Therapeutics Profile Verify Sorrento Therapeutics Emails Export Sorrento Therapeutics Prospects

Ginkgo Bioworks

ginkgobioworks.com

HQ: Boston, MA

HQ: Boston, MA

Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial

Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active

  • Christina Agapakis

    Creative Director

    c*******a@ginkgobioworks.com

  • Ken Situ

    It Consultant

    k******u@ginkgobioworks.com

  • General Inquiries

    info@ginkgobioworks.com

  • Investor Relations

    20investors@ginkgobioworks.com

Show more 7 emails
View Ginkgo Bioworks Profile Verify Ginkgo Bioworks Emails Export Ginkgo Bioworks Prospects

Horizon Discovery

horizondiscovery.com

HQ: Cambridge, Cambridgeshire, United Kingdom

HQ: Cambridge, Cambridgeshire, United Kingdom

Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics

Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active

  • Kevin Koker

    Customer Service Manager

    k*********r@horizondiscovery.com

  • Jon Aviles

    General Manager

    j********s@horizondiscovery.com

  • General Inquiries

    info@horizondiscovery.com

  • Sales Department

    sales@horizondiscovery.com

Show more 7 emails
View Horizon Discovery Profile Verify Horizon Discovery Emails Export Horizon Discovery Prospects

Loxo Oncology

loxooncology.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics

Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active

  • Lee S Scheible

    Director, Early Phase Oncology, Loxo Oncology at Lilly

    l*******e@loxooncology.com

  • Jinmi Heo

    Director

    j**o@loxooncology.com

  • General Inquiries

    info@loxooncology.com

  • Unclassified inbox

    clinicaltrials@loxooncology.com

Show more 7 emails
View Loxo Oncology Profile Verify Loxo Oncology Emails Export Loxo Oncology Prospects